BNR17 is a lactobacillus found in the breast milk of a Korean woman and is widely known as ‘milk lactobacillus’. The number 17 included in the name of this lactobacillus means the experimental number at the time of discovery. 비엔알17 유산균
Breast milk is a valuable resource rich in natural oligosaccharides and microorganisms that help children grow healthy. BNR17 lactobacillus also comes from such breast milk, so it retains the abundant ingredients contained in it.
Currently, BNR17 lactobacillus is attracting attention as a new material that can help with weight control, and its value is recognized in the United States. Moreover, for the first time in Korea, the Ministry of Food and Drug Safety has officially confirmed that this lactobacillus is effective in reducing body fat.
BNR17 lactic acid bacteria, which are called various names such as ‘VR17’ and ‘Vienna17’, are actually leaving positive experiences that many people have been helped with losing weight. Thanks to this, I was given the nickname ‘BNR17 diet lactic acid bacteria’.
In the 2018 Health Functional Raw Materials Competition, it ranked first in the weight management raw materials category, and has been recognized for its efficacy by academia, including more than 800 mentions in SCI-level papers over the past 20 years. In this article, we will learn more about the health benefits of consuming BNR17 lactobacillus.
BNR17 Lactobacillus Efficacy
1. Weight loss and obesity prevention effects
The prevalence of obesity among modern people is increasing day by day due to lack of exercise and increased consumption of high-calorie foods. Obesity is considered a major risk factor for various chronic diseases such as diabetes, cardiovascular disease, and cancer.
A balanced diet and regular exercise are essential for weight loss, but interest in the effects of probiotics to improve obesity has recently increased. Among them, BNR17 lactobacillus is known to be excellent in reducing body fat and preventing obesity.
BNR17 lactic acid bacteria balance the intestinal flora and suppress the absorption of fat. In particular, BNR17 lowers the activity of lipase, a lipase, in the intestine, thereby reducing the absorption of fat, and helps to release undissolved fat from the body.
In addition, BNR17 has the effect of preventing constipation by lowering the pH of the intestine, suppressing the proliferation of harmful bacteria, and activating the peristalsis of the intestine.
In fact, a study published in the international journal Journal of Microbiology and Biotechnology found that eight weeks of BNR17 administration in obese mice resulted in a significant decrease in body weight and visceral fat and a decrease in the size of fat cells.
2. Controlling appetite and improving satiety
One of the main causes of obesity is excessive appetite and binge eating. Stress, irregular meals, and lack of sleep make it difficult to secrete appetite-regulating hormones, which eventually leads to weight gain.
Therefore, it is important to properly control your appetite and feel full for healthy weight management, and BNR17 lactobacillus can help control your appetite and improve your satiety.
BNR17 promotes the secretion of the appetite-suppressing hormones peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, which not only stimulates the satiety center to reduce appetite and reduce food intake, but also contributes to the prevention of overeating by alleviating postprandial blood sugar rise.
In this regard, according to a clinical trial study published by a research team at Kyung Hee University, 40 obese adult men and women were given BNR17 lactobacillus for 12 weeks, and compared to the control group, hunger was significantly reduced and satiety increased.
3. Improvement of intestinal environment and prevent constipation
Modern people are prone to red flags for their intestinal health due to irregular eating habits, stress, and lack of exercise. If harmful bacteria increase in the intestine and the beneficial bacteria decrease, the environment in the intestine deteriorates and the defecation activity becomes difficult.
BNR17 is a probiotic that promotes the proliferation of beneficial bacteria in the intestine and inhibits the growth of harmful bacteria. Through this, it hinders the adhesion of pathogenic bacteria to intestinal epithelial cells and contributes to maintaining the balance of the intestinal flora by producing antibacterial substances.
According to a study published by the Korea Food Research Institute, 28 adult women with constipation were asked to take BNR17 lactobacillus and found that constipation symptoms, such as increased bowel movements and improved fecal consistency, were significantly alleviated.
4. Improving blood lipids and preventing hyperlipidemia
BNR17 inhibits the absorption of cholesterol and promotes its release. BNR17 helps cholesterol to be excreted from the body by increasing the activity of bile acid hydrolase, and contributes to lowering blood cholesterol levels by activating the process of breaking down and metabolizing cholesterol in the intestine.
According to a study published in the Japanese Academy of Agricultural and Chemicals, BNR17 was used to test high-fat diet-induced hypercholesterolemia mice, and total blood cholesterol and LDL cholesterol were significantly reduced in the BNR17-administered group, and fat accumulation in liver tissue was also suppressed.
5. a boost in immunity
The intestine is the largest immune system with more than 70% of our body’s immune cells, and it can be said that the balance of intestinal microorganisms is directly related to immune function. BNR17 Lactobacillus has been reported to be helpful in activating intestinal immunity and alleviating allergic reactions.
In particular, BNR17 not only functions to increase the immune response by activating Th1 cells, which are immune cells of the intestinal mucosa, but also suppresses the secretion of Th2 cytokines that cause allergic reactions and promotes the production of IL-10, an anti-inflammatory cytokine, to prevent the occurrence of allergic diseases.
According to an animal experimental study published by a research team at Chung-Ang University, oral administration of BNR17 lactobacillus to mice that induced allergic rhinitis for four weeks resulted in a significant decrease in the number of nasal tickles and sneezes, which are indicators of allergic symptoms, and a significant decrease in total IgE levels in the blood.